The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Hormone receptor expression and risk of recurrence in patients with high-risk endometrial carcinoma treated with chemotherapy.
Olivia Claire Barrett
No relevant relationships to disclose
Omer L. Burnett
No relevant relationships to disclose
Michael G. Conner
No relevant relationships to disclose
Yufeng Li
No relevant relationships to disclose
Jacob Michael Estes
No relevant relationships to disclose
Jennifer F. De Los Santos
No relevant relationships to disclose